Colorectal cancer in a population with a guaiac-based screening programme

被引:4
|
作者
Navarro, Matilde [1 ,2 ]
Peris, Merce [1 ,2 ]
Binefa, Gemma [1 ,2 ]
Vanaclocha, Mercedes [2 ]
Losa, Ferran [3 ]
Fernandez, Esteve [1 ,2 ,4 ]
机构
[1] Inst Catala Oncol, Serv Prevenc & Control Canc, Barcelona, Spain
[2] Inst Invest Biomed Bellvitge IDIBELL, Barcelona, Spain
[3] Hosp Gen LHosp, Barcelona, Spain
[4] Univ Barcelona, Dept Ciencies Clin, Barcelona, Spain
来源
MEDICINA CLINICA | 2009年 / 132卷 / 13期
关键词
Colorectal cancer; Screening; Guaiac-based test; Interval cancer; PARTICIPATION;
D O I
10.1016/j.medcli.2008.12.026
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background and objective: Colorectal cancer (CRC) screening effectiveness depends on the degree of implementation and population adherence. The goals of this study were to determine the number of CRC cases diagnosed in L'Hospitalet of Llobregat (Spain) and to identify the features of those cases detected by the population-based screening programme initiated in 2000 in this city. Patients and method: Patients aged 50-69 year-old with a CRC diagnosis identified by cancer registries from the hospitals of L'Hospitalet were included. Patients were classified in 4 groups according to participation in the screening programme: 1, no participants; 2 diagnosed by screening; 3 participants with a negative screening result; and 4, participants with an incomplete screening process. Results: We found 510 patients diagnosed of CRC, 88% of whom had been invited to the screening programme. The distribution by tumour stage was: 0.50 (9.8%); I, 53 (10.4%); II, 135 (26.5%); III, 154 (30.2%); IV, 105 (20.6%); and unknown, 13 (2.5%). The number of patients in each group was: 1. 350 (78.0%); 2.58 (12.9%); 3, 29 (6.5%); and 4, 12 (2.7%). CRC detected by screening and by clinical diagnosis differed in some characteristics: cancer of colon (89.7% vs 66.2%, P<.001), symptoms (32.8% vs 84.3%, P<.001) and stages (0-II 75.9% vs 42.9%. III-IV 24.1% vs 54.2%, P<.001). Discussion: These results show the benefit of a population-based screening programme. CRC detected by the screening programme is diagnosed in early stages and before disease symptoms appear. (C) 2008 Elsevier Espana, S.L. All rights reserved.
引用
收藏
页码:495 / 500
页数:6
相关论文
共 50 条
  • [41] Comparison of a brush-sampling fecal immunochemical test for hemoglobin with a sensitive guaiac-based fecal occult blood test in detection of colorectal neoplasia
    Smith, Alicia
    Young, Graeme P.
    Cole, Stephen R.
    Bampton, Peter
    CANCER, 2006, 107 (09) : 2152 - 2159
  • [42] Factors associated with participation in colorectal cancer screening: A population-based study of 7200 individuals
    Huang, Junjie
    Choi, Peter
    Pang, Tiffany W. Y.
    Chen, Xiao
    Wang, Jingxuan
    Ding, Hanyue
    Jin, Yinzi
    Zheng, Zhi-Jie
    Wong, Martin C. S.
    EUROPEAN JOURNAL OF CANCER CARE, 2021, 30 (02)
  • [43] Colorectal cancer screening programme in Aragon (Spain): preliminary results
    Sole Llop, Ma Esther
    Cano del Pozo, Mabel
    Garcia Montero, Jose-Ignacio
    Carrera-Lasfuentes, Patricia
    Lanas, Angel
    GACETA SANITARIA, 2018, 32 (06) : 559 - 562
  • [44] The effect of a screening programme on the outcome of colorectal cancer
    Suttie, S. A.
    Shaikh, I. A.
    Amin, A. I.
    Daniel, T.
    Yalamarthi, S.
    COLORECTAL DISEASE, 2012, 14 (08) : 937 - 942
  • [45] Population screening for colorectal cancer: Advantages and drawbacks
    Kronborg, Ole
    Regula, Jaroslaw
    DIGESTIVE DISEASES, 2007, 25 (03) : 270 - 273
  • [46] Uptake of colorectal cancer screening in an uninsured population
    Sarfaty, M
    Feng, SB
    PREVENTIVE MEDICINE, 2005, 41 (3-4) : 703 - 706
  • [47] Colorectal Cancer Screening and Surveillance in the Geriatric Population
    Cheong J.
    Faye A.
    Shaukat A.
    Current Gastroenterology Reports, 2023, 25 (7) : 141 - 145
  • [48] A population-based cross-sectional study of colorectal cancer screening practices of first-degree relatives of colorectal cancer patients
    Courtney, Ryan J.
    Paul, Christine L.
    Carey, Mariko L.
    Sanson-Fisher, Robert W.
    Macrae, Finlay A.
    D'Este, Catherine
    Hill, David
    Barker, Daniel
    Simmons, Jody
    BMC CANCER, 2013, 13
  • [49] Fecal immunochemical tests-what are the advantages compared to the guaiac-based fecal occult blood test?
    Brenner, H.
    Gies, A.
    GASTROENTEROLOGE, 2019, 14 (01): : 6 - 13
  • [50] Role of community pharmacies in a population-based colorectal cancer screening program
    Vives, Nuria
    Mila, Nuria
    Binefa, Gemma
    Travier, Noemie
    Farre, Albert
    Vidal, Carmen
    Sattari, Maryam
    Bagaria, Guillermo
    Garcia, Montse
    PREVENTIVE MEDICINE, 2021, 145